Checkpoint Inhibitor Combinations Therapy as First Line for Inoperable Lung Cancer Via IT
Checkpoint Inhibitor Combinations Therapy as First Line for Inoperable Lung Cancer Via IT
Recruiting · NCT06483347 · Registry updated 2024-07-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Checkpoint Inhibitor Combinations Therapy as First Line for Inoperable Lung Cancer Via IT | Neoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2024-07-03 | NCT06483347 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Second Affiliated Hospital of Guangzhou Medical University | 70 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Second Affiliated Hospital of Guangzhou Medical University | Guangzhou | China | 5 |